共 468 条
[1]
Chang SS(2016)Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline J Urol 196 1021-1029
[2]
Boorjian SA(2016)Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines Urol Oncol 34 437-451
[3]
Chou R(2017)EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016 Eur Urol 71 447-461
[4]
Clark PE(2010)Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial J Urol 183 76-80
[5]
Daneshmand S(2016)Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?—an International Bladder Cancer Network project Urol Oncol 34 452-459
[6]
Konety BR(2012)Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guerin therapy for bladder cancer: results of a prospective trial J Urol 187 862-867
[7]
Pruthi R(2017)Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer Eur Urol 71 462-475
[8]
Quale DZ(2018)An update on the molecular pathology of urinary bladder tumors Pathol Res Pract 214 1-6
[9]
Ritch CR(2003)Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Urology 61 109-118
[10]
Seigne JD(2016)The Paris system for reporting urinary cytology: the quest to develop a standardized terminology Acta Cytol 60 185-197